NASDAQ
Caribou Biosciences, Inc. (CRBU) reported revenue of $11.16M and net income of $-148,125,000 for FY 2025, with a net profit margin of -1327.4%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.